Cigna

iPMI Market Interviews

Interviews

iPMI Global Speaks with Chris Carter, CEO, ExpatInsure

The International Private Medical Insurance (IPMI) sector has long been defined by legacy giants, complex policy jargon and traditional corporate packages. As the modern expat demographic shifts towards digital nomads, independent professionals and micro-multinationals, the industry is being forced to rethink.  In this exclusive iPMI Global Interview, we sit down with Chris Carter, CEO of ExpatInsure, to discuss the company's growth, how it is using technology to strip the complexity out of buying cover, and why the model of the bloated...

18-06-2026 iPMI Global

Interviews

iPMI Global Speaks with Gitte Bach, CEO, New Frontier Group

iPMI Global, the leading business intelligence platform for the international private medical insurance (IPMI) and global assistance sectors, has officially released its latest executive round table report, titled "The Algorithmic Gatekeeper: AI and the Future of IPMI." Featuring crucial insights from New Frontier Group CEO Gitte Bach, “The Algorithmic Gatekeeper” maps the transition from manual administration to intelligent clinical navigation. A primary focal point of the round table is the critical necessity for "explainability" and human accountability as artificial intelligence begins to...

22-05-2026 iPMI Global

iPMI Market Providers

UK Insurance Broker Charged with Alleged Failing to Prevent Bribery in Ecuador by Serious Fraud Office (SFO)

The UK Serious Fraud Office (SFO) has announced that it has charged United Insurance Brokers Limited (UIBL), a UK insurance and reinsurance broker, with allegedly failing to prevent international bribery. The charges relate to alleged bribery of state officials in Ecuador between October 2013 and March 2016, facilitated by UIBL's US-based intermediaries. The SFO alleges that these intermediaries paid bribes to secure re-insurance contracts worth US$38 million for UIBL, which earned a US$6.2 million commission. Representatives of UIBL are scheduled to appear before Westminster Magistrates’ Court next month. This case is significant as it could be the first time an SFO "failure to prevent bribery" case is heard by a jury.

Key Themes

  • SFO Charges UK Insurer: The central point is the SFO's decision to formally accuse UIBL of a criminal offense: "The Serious Fraud Office (SFO) today accused a UK insurance company of failing to prevent international bribery." This signifies a formal legal process has been initiated against the company.
  • Nature of the Offense: UIBL is charged specifically with "failing to prevent associates from bribing state officials in Ecuador between October 2013 and March 2016." This highlights that the company itself is not directly accused of bribery, but rather of not having adequate measures in place to prevent its intermediaries from doing so.
  • Alleged Bribery Scheme: The SFO alleges a specific mechanism through which the bribery occurred. UIBL's "US-based intermediaries for Ecuador paid bribes in return for the awarding of re-insurance contracts worth US$38 million." This outlines the quid pro quo nature of the alleged corruption.
  • Financial Dimensions: The case involves significant financial figures. The re-insurance contracts were worth US$38 million, and UIBL received a "US$6.2 million commission" for providing these services. Of this commission, "US$3 million was allegedly paid to intermediaries," who are then accused of using these funds to bribe an Ecuadorian official.
  • Beneficiaries of Re-insurance: The re-insurance services provided by UIBL were sold to "state insurers covering parts of the Ecuadorian public sector, including the state water and electricity companies." This emphasizes the potential impact of the alleged corruption on public services in Ecuador.
  • Significance of Potential Jury Trial: The press release notes the potential landmark nature of the case: "If this case proceeds to a contested trial, it will be the first time that an SFO “failure to prevent bribery” case is heard by a jury." This underscores the legal and precedential importance of the proceedings.
  • SFO's Stance on International Bribery: Nick Ephgrave QPM, Director of the SFO, is quoted emphasizing the agency's commitment: "The SFO remains committed to stamping out international bribery wherever it may occur." He further states the responsibility of British companies: "British companies have a duty to prevent the harm caused by bribery when doing business at home and abroad, to ensure that the UK remains a safe and fair place to do business." These quotes highlight the SFO's proactive approach to combating overseas corruption.
  • Next Steps in the Legal Process: The immediate next step is the appearance of UIBL representatives before "Westminster Magistrates’ Court on Wednesday 7 May to face the charges." This marks the beginning of the formal legal proceedings.

Implications

  • Legal Precedent: As potentially the first "failure to prevent bribery" case heard by a jury in the UK, the outcome of this trial could set a significant precedent for how such offenses are prosecuted and judged in the future.
  • Corporate Responsibility: The case serves as a reminder of the legal obligation under UK law for companies to have adequate procedures in place to prevent bribery by their associated persons, both domestically and internationally.
  • International Anti-Corruption Efforts: This action by the SFO aligns with broader international efforts to combat corruption and ensure fair business practices across borders.
  • Reputational Risk: For UIBL, the charges themselves and any subsequent trial will carry significant reputational risks, potentially impacting their business operations and relationships.
  • Increased Scrutiny: This case may lead to increased scrutiny of UK companies operating in sectors and regions perceived to have a higher risk of corruption.

Further Considerations:

  • The press release provides the SFO's perspective on the matter. Further information will likely emerge as the legal proceedings unfold, including UIBL's defense and the evidence presented by both sides.
  • Understanding the specific deficiencies in UIBL's bribery prevention procedures, as alleged by the SFO, would provide further insight into the case.

This briefing article summarises the key information provided in the GOV.UK press release regarding the alleged charges against United Insurance Brokers Limited. It highlights the significance of the case in the context of the UK's efforts to combat international bribery.

Source: https://www.gov.uk/government/news/uk-insurer-charged-with-bribery-in-ecuador

iPMI Global Network Directory

iPMI Global Launches July 2026 Global Provider Network Directory to Streamline B2B Sourcing and Glob…

14-07-2026 Network Directory iPMI Global

iPMI Global, the preeminent business intelligence resource for the international medical insurance sector, today announced the official release of the July 2026 edition of its Global Provider Network Directory. This directory serves as a mission-critical infrastructure tool for senior executives navigating the increasingly complex landscape of global B2B healthcare sourcing. Engineered to function as the definitive online B2B buyer’s guide, the directory eliminates the friction inherent in international partnership identification, providing a standardized, high-impact framework for insurers, hospitals, assistance companies, and third-party administrators (TPAs).

iPMI Global Unveils June 2026 Provider Network Directory: The Authoritative B2B Guide for Internatio…

19-06-2026 Network Directory iPMI Global

iPMI Global, the leading provider of business intelligence for the International Private Medical Insurance (iPMI) sector, today announced the launch of the June 2026 edition of its Global Provider Network Directory. Serving as the definitive online B2B buyer’s guide, this resource is engineered to streamline the identification of global partnerships for insurers, hospitals, assistance companies, and third-party administrators. In an industry where "right place, right time" care delivery is critical, iPMI Global provides a high-impact solution for industry payers looking to expand their service capabilities. The directory centralizes comprehensive company intelligence, offering a single, authoritative platform for executives to navigate the complex international healthcare ecosystem and secure seamless global reach. Discover the June 2026 iPMI Global Provider Network Directory—the definitive B2B buyer's guide for international healthcare sourcing, partnership identification, and market intelligence.

Welcome To iPMI Global

iPMI Global is the leading business intelligence provider for international private medical and expatriate healthcare insurance markets worldwide. Due to the nomadic nature of the international private medical insurance (iPMI) market, iPMI Global is an internet based business intelligence  service for worldwide insurance and medical assistance professionals, who need to understand the impacts of insurance and healthcare policy, regulatory, and legislative developments.

For the past 15 years senior level business executives, in over 120 countries, rely on iPMI Global to stay 1 step ahead of the risk and on the inside track of international private medical insurance.

Covering business travellers, high net worth individuals, expatriate and leisure travel markets, iPMI Global is the only international news source covering the most exciting sector of international health insurance: international private medical insurance.

Socials